Please assess the completion status of the following clinical trial:

Trial Title: The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* ASA (American Society of Anesthesiologists) I-III patients scheduled for elective one or two level minimally invasive lumbar fusions~Exclusion Criteria:~* Patients requiring surgery for neoplastic processes~* Allergy to acetaminophen~* Liver dysfunction and elevated Liver Function Tests (LFTs)~* Alcohol or drug dependency~* Mental retardation~* Less than 50 kg of weight~* regnant women~* Patients requiring long-acting opioid pain management (including fentanyl patch, oxycontin, etc) for over 3 weeks immediately prior to surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Acetaminophen IV Soln 10 MG/ML (A) (Type: EXPERIMENTAL): Patients in group A will receive 1 g of IV acetaminophen 15 minutes prior to wound incision, and every 4 to 6 hours postoperatively for a total of 4 grams in 24 hours.
- PO acetaminophen (B) (Type: EXPERIMENTAL): Patients in group B will receive 1 g of PO acetaminophen prior to surgery, and 1 g of oral acetaminophen every 4 to 6 hours postoperatively for a total of 4 grams in 24 hours.
- Hydromorphone (control arm) (C) (Type: ACTIVE_COMPARATOR): Patients in the control arm (Group C) will not receive acetaminophen for 24 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).